Filter by Category: SENTRY Surveillance

In vitro activities of BMS-207147 against over 600 contemporary clinical bloodstream isolates of Candida species from the SENTRY Antimicrobial Surveillance Program in North America and Latin America.

In vitro activities of BMS-207147 against over 600 contemporary clinical bloodstream isolates of Candida species from the SENTRY Antimicrobial Surveillance Program in North America and Latin America. by Diekema DJ, Pfaller MA, Messer SA, Houston A, Hollis RJ, Doern GV and Jones RN published in Antimicrob. Agents Chemother. 1999; 43 (9): 2236-2239

Survey of bloodstream infections due to Gram-negative bacilli: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997.

Survey of bloodstream infections due to Gram-negative bacilli: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997. by Diekema DJ, Pfaller MA, Jones RN, Doern GV, Winokur PL, Gales AC, Sader HS, Kugler K, and Beach M published in Clin. Infect. Dis. 1999; 29 (3): 595-607

Current susceptibilities of staphylococci to glycopeptides determined as part of an international resistance surveillance programme. SENTRY Antimicrobial Surveillance Program.

Current susceptibilities of staphylococci to glycopeptides determined as part of an international resistance surveillance programme. SENTRY Antimicrobial Surveillance Program. by Jones ME, Jones RN, Sader H, Verhoef J and Acar J published in J. Antimicrob. Chemother. 1998; 42 (1): 119-121

Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 Results from the SENTRY Antimicrobial Surveillance Program.

Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY Antimicrobial Surveillance Program. by Doern GV, Pfaller MA, Kugler K, Freeman J and Jones RN published in Clin. Infect. Dis. 1998; 27 (4): 764-770

The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada – 1997 results from the SENTRY Antimicrobial Surveillance Program.

The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada – 1997 results from the SENTRY Antimicrobial Surveillance Program. by Doern GV, Pfaller MA, Erwin ME, Brueggemann AB and Jones RN published in Diagn. Microbiol. Infect. Dis. 1998; 32 (4): 313-316

Fluoroquinolone-resistant Moraxella catarrhalis in a patient with pneumonia: Report from the SENTRY Antimicrobial Surveillance Program (1998).

Fluoroquinolone-resistant Moraxella catarrhalis in a patient with pneumonia: Report from the SENTRY Antimicrobial Surveillance Program (1998). by DiPersio JR, Jones RN, Barrett T, Doern GV and Pfaller MA published in Diagn. Microbiol. Infect. Dis. 1998; 32 (2): 131-135

Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: Analysis of results from the SENTRY Antimicrobial Surveillance Program (1997). SENTRY Latin America Study Group.

Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: Analysis of results from the SENTRY Antimicrobial Surveillance Program (1997). SENTRY Latin America Study Group. by Sader HS, Jones RN, Gales AC, Winokur P, Kugler KC, Pfaller MA and Doern GV published in Diagn. Microbiol. Infect. Dis. 1998; 32 (4): 289-301

International surveillance of bloodstream infections due to Candida species: Frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group.

International surveillance of bloodstream infections due to Candida species: Frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group. by Pfaller MA, Jones RN, Doern GV, Sader HS, Hollis RJ and Messer SA published in J. Clin. Microbiol. 1998; 36 (7): 1886-1889

Bacterial pathogens isolated from patients with bloodstream infection: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997).

Bacterial pathogens isolated from patients with bloodstream infection: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). by Pfaller MA, Jones RN, Doern GV and Kugler K published in Antimicrob. Agents. Chemother. 1998; 42 (7): 1762-1770